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Volume 51, Number 4 Abstracts 106998.8%]) and OSR (100%, P  .05). The 5-year all-cause survival was
significantly reduced in the EVAR group (50.4%, 95% CI, 34%-66%.) vs
OSR (80.4%, [95% CI, 66.9%-89.5%; P  .0279; h, 0.34 [95% CI, 0.12-
0.94]). However, none of the deaths in the EVAR group were aneurysm-
related. The 30-day morbidity (P  .0001), length of hospital stay (P 
.0001), 5-year quality-adjusted time spent without symptoms of disease and
toxicity of treatment (P  .01), and cost per QALY (P  .01) were all
significantly reduced with EVAR compared with OSR.
Conclusions: Endografts can be effectively used to treat difficult
pararenal AAAs, with enhanced long-term aneurysm-related survival,
cost-effectiveness, and quality of life, and with significantly reduced
perioperative morbidity, mortality, and waiting time from diagnosis to
treatment.
DuplexUltrasound Factors Predicting Persistent Type II Endoleak and
Increases in Abdominal Aortic Aneurysm Sac Diameter After Endovas-
cular Aneurysm Repair
Brian R. Beeman, MD, Kathy Murtha, RVT, Kevin Doerr, RVT, Sandy
McAfee-Bennett, RVT, Matthew J. Dougherty, MD, and Keith D. Calligaro,
MD, Pennsylvania Hospital, Philadelphia, Pa, USA
Objective: Although the significance of type II endoleaks (T2ELs) on
the long-term outcome of endovascular repair (EVAR) of abdominal aortic
aneurysms (AAAs) is debatable, duplex ultrasound (DUS) parameters have
been suggested to be predictive of their closure or persistence. The purpose
of this study was to determine which, if any, of these variables was associated
with persistent T2ELs or increased AAA sac diameter.
Methods: Between 1998 and 2009, 278 patients underwent EVAR
and postoperative DUS surveillance during long-term follow-up (range,
1-11 years) in our accredited noninvasive vascular laboratory by one of three
experienced technologists. DUS was used to measure intrasac flow velocity
(IFV), spectral Doppler waveform (SDW) patterns, post-EVAR sac diame-
ter, and number of T2ELs per patient.
Results: T2ELs developed in 38 patients (14%) after EVAR: 14 had
T2ELs that resolved and sac diameter decreased or remained the same
(average IFV, 42 cm/s). SDW patterns were monophasic in 5, biphasic in 7,
and bidirectional in 2. Multiple T2ELs were not present (0%) in any patient.
Twelve patients had T2ELs that persisted but sac diameter decreased or
remained the same (average IFV, 47 cm/s). SDW patterns were
monophasic in 1, biphasic in 5, bidirectional in 5, and undetermined in 1.
Multiple T2ELs were found in two patients (17%). T2ELs persisted in 12
patients and were associated with increased sac diameter (average IFV, 43
cm/s). SDW patterns were monophasic in 1, biphasic in 2, and bidirec-
tional in 9. Multiple T2Els were identified in nine patients (75%). None
of the 38 patients with T2ELs treated with selective surgical or endovas-
cular intervention for enlarging sac diameters (9 of 12) experienced a
ruptured aneurysm.
Conclusions: Contrary to previous reports, parameters such as
intrasac flow velocity and spectral Doppler waveform patterns of T2ELs
did not correlate with increased post-EVAR sac diameter. The presence
of multiple T2ELs may be the strongest factor predictive of increased sac
diameter.
Table. Patency data for percutaneous transluminal angiop
Variable 6 mon 12 mon
Primary patency
Female 75.5  3.3 66.9  3
Male 60.5  3.2 48.1  3
P .001 .0001
Primary-assisted patency
Female 80.0  3.0 75.2  3
Male 66.7  3.1 57.5  3
P .003 .0001
Secondary patency
Female 81.8  2.9 79.1  3
Male 69.2  3.0 62.6  3
P .004 .001
Limb salvage
Female 89.7  2.4 88.2  2
Male 80.7  2.6 74.0  3
P .005 .001DuplexUltrasoundGraft LimbVelocity Asymmetry Predicts Endoleak
After Endovascular Aneurysm Repair
Shardul B. Nagre, MBBS, Marc A. Passman, MD, Bart R. Combs, MD,
Bruce G. Lowman, MD, and William D. Jordan Jr, MD, University of
Alabama at Birmingham, Birmingham, Ala, USA
Objective: Ultrasound (US) surveillance after endovascular aneurysm
repair (EVAR) may be suboptimal compared with computed tomography
(CT) imaging due to its limited ability to assess the complete stent graft and
aneurysm sac. We evaluated our US surveillance program to identify surro-
gate markers independent of CT that may predict endoleak after EVAR.
Methods: Patient records were reviewed for all EVAR procedures
performed between October 1999 and June 2009 from our prospectively
maintained database. Postoperative surveillance protocol involved CT and
US imaging 30 days and at 6- and 12-month intervals. US imaging
parameters included maximum aneurysm diameter, presence of endoleak,
and graft limb flow velocities that were considered asymmetric if they
differed by 5 cm/s.
Results: During this 10-year period, 927 patients underwent 1062
EVAR procedures and 3120 postoperative imaging encounters, of which
1589 (50.9%) had US imaging. US identified an endoleak in 186
encounters (11.7%): 17 type I, 166 type II, and 3 type III. Asymmetric
graft limb velocity (AGLV) was identified in 494 US encounters (30.9%),
of which 150 US images (9.4%) had endoleak, and 36 endoleaks (2.3%)
were identified in those encounters with symmetric velocities. Logistic
regression showed a significant association between AGLV and any type
of endoleak (odds ratio [OR], 12.9; 95% confidence interval [CI],
8.8-18.9; P  .0001). Further analysis showed a significant association
between AGLV and type I (OR, 7.4; 95% CI, 2.6-21.3; P  .0002) and
type II endoleaks (OR, 13.5; 95% CI, 9.0-20.3; P  .0001). CT
comparison of 561 encounters from the same cohort identified a signif-
icant association between AGLV and any type of endoleak identified on
CT (OR, 1.5; 95% CI, 1.05-2.3; P .026), or CT type II endoleak (OR,
1.6; 95% CI, 1.1-2.4; P  .022).
Conclusions: Asymmetric graft limb velocities during US surveillance
may act as a surrogate marker to predict endoleaks that are not directly
visualized by US. Using graft limb velocities may simplify the surveillance
protocol after EVAR and may reduce the need for repeated CT imaging.
Gender Differences in the Outcome of Endovascular Interventions for
Peripheral Arterial Disease: Is There a Difference Between Men and
Women Treated with Angioplasty or Angioplasty and Stenting?
Katherinen A. Gallagher, MD, Ashley R. Graham, BS, Gautam Shrikhande,
MD, Combiz Rezayat, MD, Peter Connelly, MD, Hafiz Hussain, MD, Harry
L. Bush, MD, John K. Karwowski, MD, and James F. McKinsey, MD, Weill
Cornell Medical Center/Columbia University Hospital, New York, NY, USA
Objective: The expression and presentation of peripheral arterial dis-
ease (PAD) differs between men and women; however, the outcomes based
on endovascular technique and gender are unknown. This study assessed the
outcomes of women compared with men treated with lower extremity
percutaneous transluminal angioplasty (PTA) alone or PTA and stenting
(PTAStent) to determine the optimal therapy.
Methods: We performed a prospective study evaluating the outcomes
of PTA and PTAStent for PAD. Indications for intervention included
alone in men vs women
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April 20101070 Abstractsclaudication or chronic limb ischemia (CLI). Patients were monitored
clinically and with noninvasive laboratory testing for 30 months. Primary,
primary-assisted, and secondary patency and limb salvage were the primary
end points. Lesion location and length were evaluated for both groups.
Statistical analysis was performed using Kaplan-Meier and log-rank tests.
Results: Between 2004 and 2009, 984 lesions were analyzed in 407
patients (172 women and 235 men), of which 511 lesions were treated with
primary PTA and 473 were treated with PTAStent. There was no statistical
difference between the lesion distribution and characteristics of the PTA-
alone and PTAStent groups based on gender. The primary, primary-
assisted, secondary patency, and limb salvage in women treated with PTA
alone was significantly improved (P  .005) at all time points compared
with men undergoing PTA alone (Table). Outcomes after PTAStent for
men and women were similar for primary, primary-assisted, and secondary
patency at all intervals. Men had an improvement when PTAStent was
compared with PTA alone at all time intervals and patencies (P  .05).
There was also a statistically significant advantage for limb salvage in women
treated with PTA compared with men.
Conclusions: Women have significantly improved primary, primary-
assisted, secondary patency, and limb salvage rates compared with men after
treatment with PTA, and this should be the primary endovascular treatment
option for women; however, men may be better managed with primary
PTAStent. Table.
Postprocedural Duplex-calculated Blood Flow Measurements Corre-
late to Stent Patency at 12 Months
Ankur Chandra, MD,a Peter F. Lawrence, MD,b and Brian G. DeRubertis,
MD,b Division of Vascular Surgery, Ronald Regan University of California
Los Angeles (UCLA) Medical Center, Los Angeles, Califa; and Division of
Vascular Surgery, Ronald Regan UCLA Medical, Los Angeles, Calif, USAb
Objective: The utility of duplex surveillance of arterial stents has been
controversial, primarily aimed at detecting in-stent restenosis. Although veloc-
ities are commonly reported, they do not represent blood flow. The patency of
arterial prostheses is flow-dependant. We performed a preliminary evaluation of
consecutive patients to determine if postprocedural duplex-calculated blood
flows through stents correlate with 12-month primary patency.
Methods: Consecutive patients undergoing arterial stent placement
were retrospectively reviewed. Information regarding demographics, co-
morbidities, stent size, postprocedural duplex information, and 12-month
patency were recorded. Blood flow was calculated using duplex velocities
and stent dimensions.
Results: The study comprised 27 consecutive patients (age, 72.6 14
years, 14 men) with 35 stents (18 iliofemoral, 10 carotid, and 7 subclavian/Fig.mesenteric). Mean time from the procedure to the duplex study was 47 days.
At 12 months, 20 stents were primarily patent (PP) and 15 were secondarily
patent (SP). There was a significant difference between the PP and SP groups
with respect to initial in-stent mean velocities (92.5 cm/s PP vs 43.7 cm/s
SP, P .002;) and calculated flows (1918 mL/min PP vs 722 mL/min SP,
P .0001).With these threshold values, calculated flows had corresponding
sensitivity, specificity, and accuracy of 92%, 82%, and 86.2%, respectively, for
predicting stent patency, whereas those for velocity measurements were
lower at 83%, 71%, and 76%, respectively. Receiver operating characteristic
(ROC) curve (Fig) analysis showed a significantly greater area under the
curve for calculated flows compared with velocity measurements (0.965 vs
0.859, P  .001).
Conclusions: Calculated blood flows from an initial postprocedural
duplex study accurately correlate to stent patency at 12 months. By ROC
analysis, velocities alone were less sensitive, less specific, and less accurate.
This preliminary findingmandates prospective analysis of this technique with
individual vascular beds and larger patient populations. A clinical protocol
guiding stent surveillance and decisions for early reintervention is suggested.
Limitations of Re-entry Devices in Lower Extremity Chronic Total
Occlusions
Susanna H. Shin, MD, Donald Baril, MD, Rabih Chaer, MD, Robert Rhee,
MD, Michel Makaroun, MD, and Luke Marone, MD, University of Pitts-
burgh Medical Center, Pittsburgh, Pa, USA
Objective: Subintimal recanalization for the treatment of chronic total
occlusions (CTO) occasionally requires re-entry devices to access the true
lumen distally. Limited information is available on factors predicting the
success or failure of these devices.
Methods: All CTO cases from August 2006 to August 2009 were
retrospectively reviewed. Age, gender, occlusion length, site of re-entry, and
the angle of the aortic bifurcation were recorded. A calcification score (none,
mild, moderate, severe) at the re-entry site was assigned based on procedural
angiograms. Univariate and multivariate logistic regression analyses were
used to identify factors predicting failure of re-entry into the true lumen. The
Outback LTD re-entry device (Cordis) was used in all cases.
Results: Of 249 CTOs treated, the re-entry device was used 52 times
(20.9%), comprising 47 superficial femoral artery (SFA) occlusions and 5
combined SFA and popliteal artery occlusions (33 TransAtlantic Intersociety
Consensus II type C and 18 type D lesions). Of 48 procedures with available
angiograms for review, the target re-entry site was at the adductor canal in 30
(62.5%), the above-knee popliteal artery in 13 (27.1%), the behind the knee
joint in 4 (8.3%), and the mid-SFA in 2 (4.2%). The mean age was 73.1 years
(54.0% men). Re-entry was successful in 34 attempts (64.5%). Causes of
failure included inability to re-enter the true lumen in 11 (61.1%), difficulty
tracking the device over a wire in 3 (16.7%), acute angle of aortic bifurcation
in 2 (11.1%), mechanical failure of the device in 1 (5.6%), and difficulty
tracking the device through the lesion in 1 (5.6%). Moderate or severe
calcification at the site of re-entry was the only significant predictor of failure
(odds ratio, 6.3; P  .01). An aortic bifurcation angle 40° did trend
toward predicting success (odds ratio, 0.23; P  .54).
Conclusions: Although re-entry devices can be successful in extending
the applicability of endovascular management to difficult femoropopliteal
occlusions, they are not uniformly successful in current clinical practice.
Significant calcification at the proposed re-entry site is a strong predictor of
failure.
Infrageniculate Interventions in Female Patients: Improved Patency
Rates but Higher Rates of Postoperative Complications
Tejas R. Shah, MD, Angeliki Vouyouka, MD, Daniel K. Han, BA, Sharif
Ellozy, MD, Robert Lookstein, MD, Prasad Shirvalkar, MS, Michael Marin,
MD, and Peter L. Faries, MD,Mount Sinai Medical Center, New York, NY,
USA
Introduction: Infrageniculate arterial disease is increasingly treated
with endovascular management as an alternative to open surgery. Although
previous studies have analyzed the effect of gender on the success of other
arterial interventions, little is known about outcomes of infrageniculate
interventions between men and women.
Methods: Infrageniculate interventions were retrospectively reviewed
in a prospectively maintained database from 1999 to 2009. Primary end
points included technical success, limb salvage, primary patency, and sec-
ondary patency rates. Secondary end points included access site complica-
tions (ie, hematoma, thrombosis) and systemic complications (ie, myocar-
dial infarction, death).Results: Between July 1999 and November 2009, 329 tibial lesions
were treated in 277 patients, comprising 152 men (mean age, 71.4  13.1
